Dr. Israel Fernández Cadenas is a Biologist and Head of the Pharmacogenomics and Genetics Group of the IIB Sant Pau and Sant Pau Hospital. Dr. Fernández Cadenas is the co-Chair of the Acute endophenotypes working group of the ISGC and co-Chair of the Global Alliance of Acute and long term Outcome an initiative of the ISGC to study the genetics of stroke outcomes. He is the founder and coordinator of the Spanish Stroke Genetics Consortium (www.genestroke.com) and is the current Chair of the International Stroke Genetics Consortium (2021-2023). Dr. Fernández Cadenas is interested in the genetics of stroke outcomes and the pharmacogenetics of rt-PA and oral anticoagulants. He is also interested in epigenetics and gut microbiome in relation to stroke risk and stroke outcome.